On June 10, 2024, Pennsylvania House Republican Leader Bryan Cutler (R-Lancaster) expressed approval for the bipartisan House passage of legislation he co-prime sponsored. The bill mandates insurance coverage for biomarker testing in Pennsylvania.
“Biomarker testing not only saves money by providing precision medicine to better treat diseases like cancer and ALS, but—more importantly—it produces better outcomes for patients,” Cutler stated. “I thank my House colleagues on both sides of the aisle for supporting this legislation, which is so important to Pennsylvanians, their families, and caretakers who are working together to fight complex disease.”
Cutler highlighted his collaboration with Rep. Kyle Mullins (D-Lackawanna) and other stakeholders in advancing the legislation through the House.
“This legislation is personal to not only Rep. Mullins and me, but also to many Pennsylvanians who are hoping for a better future in fighting complex diseases,” Cutler said. “I will continue working with all stakeholders to engage the Senate on final legislation so we can deliver on the coverage of precision medicine for Pennsylvania patients and families who are looking for a little relief in difficult circumstances.”
House Bill 1754 passed the Pennsylvania House of Representatives with a vote of 200 to 1. It now proceeds to the Senate for consideration.
